News & Insights Search

The Indian government has approved a program for monitoring adverse events associated with medicines and biological products used in organ and tissue transplantation.

Singapore’s Health Sciences Authority (HSA) has expanded regulatory reliance and cooperation activities with partners in Africa, Asia, and Europe.

Singapore’s Parliament has advanced legislation to build “a more coherent, future-ready system” that provides clarity and predictability for the healthcare industry.

The Indian government has simplified the regulatory framework for outsourced sterilization of medical devices as part of a push to support businesses.

Australia’s Therapeutic Goods Administration (TGA) has started a consultation into proposed changes to support automated decision making (ADM) for listed medicine variation applications.

The Saudi Food and Drug Authority (SFDA) has launched the New Accelerator Program for Drugs in Rare Diseases (NADR) to streamline the development, evaluation, and authorization of drugs for rare diseases.

The Indian government is preventing applicants who submit misleading, fake, or fabricated documents from filing further requests with regulatory authorities.

The Therapeutic Goods Administration (TGA) has proposed adopting 11 international scientific guidelines for use in Australia.

Australia’s Therapeutic Goods Administration (TGA) recently announced that it has adopted 23 international scientific guidelines from European Medicines Agency (EMA), the International Council for Harmonisation (ICH), and the US Food and Drug Administration (FDA).

Australia’s Therapeutic Goods Administration (TGA) is holding a consultation to inform changes to the regulatory framework for digital mental health tools (DMHTs).